Compare ANL & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | GMM |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | Cayman Islands | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 39.6M |
| IPO Year | 2023 | 2023 |
| Metric | ANL | GMM |
|---|---|---|
| Price | $1.64 | $1.26 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.5K | 16.3K |
| Earning Date | 04-20-2026 | 08-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.79 |
| Revenue | N/A | ★ $48,171,048.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.72 |
| Revenue Growth | N/A | ★ 41.74 |
| 52 Week Low | $0.88 | $1.23 |
| 52 Week High | $2.99 | $4.97 |
| Indicator | ANL | GMM |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 31.74 |
| Support Level | $0.88 | $1.28 |
| Resistance Level | $1.59 | $1.41 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 92.82 | 28.25 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.